Lubricant, eye
ARTG ID: 370296 · Abbvie Pty Ltd · Allergan Sales LLC · Class IIa · Started June 28, 2021
Good Name: Abbvie Pty Ltd - Lubricant, eye
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 370296
- Start Date
- June 28, 2021
- Effective Date
- June 28, 2021
- Name
- Abbvie Pty Ltd
- Country
- United States of America
- Address
- 2525 Dupont Drive, Irvine, CA, 92612
A sterile substance used to provide supplemental lubrication/hydration to the natural eye to treat dry, tired, and/or strained eyes resulting from dry eye syndrome (a disorder resulting in dry, gritty, burning symptoms), ageing/hormone changes (menopause), or environmental factors (e.g. medications, pollution, computer use, air conditioning, and contact lens use).
Access comprehensive regulatory information for Lubricant, eye in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 370296 and sponsored by Abbvie Pty Ltd, manufactured by Allergan Sales LLC in United States of America. The device registration started on June 28, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.